Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Drewa

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
European Urology|October 28, 2008
Re: Fritz H. Schröder, Karl-Heinz Kurth, Sophie D. Fossa, et al. Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial). Eur Urol 2009;55:14-22Tomasz Drewa
European Urology|April 6, 2010
Re: Per-Anders Abrahamsson. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010;57:49-59Tomasz Drewa
Regenerative Medicine|October 25, 2008
Using hair-follicle stem cells for urinary bladder-wall regenerationTomasz Drewa
European Urology|November 17, 2009
Re: Minja J. Pfeiffer, Jack A. Schalken. Stem cell characteristics in prostate cancer cell lines. Eur Urol 2010;57:246-55Tomasz Drewa
European Urology|October 24, 2008
Re: Udo Nagele, Sabine Maurer, Gerard Feil, et al. In vitro investigations of tissue-engineered multilayered urothelium established from bladder washings. Eur Urol 2008;54:1414-22Tomasz Drewa
Central European Journal of Urology|March 1, 2014
Following the guidelines is the easiest and safest of all, but life is not easyTomasz Drewa
European Urology|July 8, 2008
Re: Fritz H. Schröder. Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms. Eur Urol 2008;53:1129-37Tomasz Drewa
Acta Poloniae Pharmaceutica|May 23, 2007
The urothelium cell culture on the starch scaffoldTomasz Drewa
The Journal of Urology|June 19, 2012
The promises and challenges of tissue engineering for urinary diversionTomasz Drewa
Pharmacological Reports : PR|April 26, 2016
Pharmacotherapy in detrusor underactivity: A new challenge for urologists and pharmacologists (from lab to clinic)Kajetan Juszczak, Tomasz Drewa
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
European Urology|October 28, 2008
Re: Fritz H. Schröder, Karl-Heinz Kurth, Sophie D. Fossa, et al. Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial). Eur Urol 2009;55:14-22Tomasz Drewa
European Urology|April 6, 2010
Re: Per-Anders Abrahamsson. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol 2010;57:49-59Tomasz Drewa
Regenerative Medicine|October 25, 2008
Using hair-follicle stem cells for urinary bladder-wall regenerationTomasz Drewa
European Urology|November 17, 2009
Re: Minja J. Pfeiffer, Jack A. Schalken. Stem cell characteristics in prostate cancer cell lines. Eur Urol 2010;57:246-55Tomasz Drewa
European Urology|October 24, 2008
Re: Udo Nagele, Sabine Maurer, Gerard Feil, et al. In vitro investigations of tissue-engineered multilayered urothelium established from bladder washings. Eur Urol 2008;54:1414-22Tomasz Drewa
Central European Journal of Urology|March 1, 2014
Following the guidelines is the easiest and safest of all, but life is not easyTomasz Drewa
European Urology|July 8, 2008
Re: Fritz H. Schröder. Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms. Eur Urol 2008;53:1129-37Tomasz Drewa
Acta Poloniae Pharmaceutica|May 23, 2007
The urothelium cell culture on the starch scaffoldTomasz Drewa
The Journal of Urology|June 19, 2012
The promises and challenges of tissue engineering for urinary diversionTomasz Drewa
Pharmacological Reports : PR|April 26, 2016
Pharmacotherapy in detrusor underactivity: A new challenge for urologists and pharmacologists (from lab to clinic)Kajetan Juszczak, Tomasz Drewa
Pageof 25